Investors Overview

Corporate Profile

Bacterin International Holdings, Inc., Belgrade, MT (NYSE: BONE), a developer of bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allografts for transplantation. The Company’s biologic scaffolds, OsteoSponge®, OsteoSponge® SC and OsteoWrap®, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast® and OsteoLock®, which are used in ...
More

Stock Quote
BONE (Common Stock)
ExchangeNYSE (US Dollar)
Price$2.59
Change (%) Stock is Down 0.02 (0.77%)
Volume13,754
Data as of 12/24/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock Chart
Stock chart for: 03NA000000BONE
Recent News
DateTitle 
11/26/14Bacterin to Present at the 7th Annual LD Micro Conference
BELGRADE, Mont., Nov. 26, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, will present at the LD Micro Conference 7th Annual Main Event, to be held December 4, 2014 at the Luxe Hotel in Los Angeles, CA. Bacterin's presentation will take place Thursday, December 4, 2014 at 1:30pm PT. Institutional investors that wish to re... 
Printer Friendly Version
11/17/14Bacterin to Present at the Singular Research 9th Annual Best of the Uncovereds Conference
BELGRADE, Mont., Nov. 17, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, will present at the Singular Research 9th Annual Best of the Uncovereds Conference, to be held November 20, 2014 at the Westin in New York at Times Square. Bacterin's presentation will take place Thursday, November 20, 2014 at 10:30am ET. Institutio... 
Printer Friendly Version
11/14/14Bacterin Receives Delisting Notice From NYSE MKT
BELGRADE, Mont., Nov. 14, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE) today announced that the Company received notice that the staff of NYSE Regulation, Inc. has determined to commence proceedings to delist the Company's common stock from the NYSE MKT LLC ("NYSE MKT" or the "Exchange") because the Company did not cure its non-compliance with Sections 1003(a)(i), (ii) and (iii) of the NYSE MKT Company Guide by the end of the maximum 18 month compliance plan per... 
Printer Friendly Version
11/11/14Bacterin CEO Dan Goldberger to be Guest on FOX Business Network's After the Bell with Liz Claman
BELGRADE, Mont., Nov. 11, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE:BONE) today announced its CEO Dan Goldberger will be a guest on FOX Business Network's After the Bell with Liz Claman at approximately 4:15 PM/ET on Tuesday, November 11, 2014. Bacterin is a medical device company and accredited tissue bank that designs, processes, manufactures, and markets advanced medical products. During the show, Mr. Goldberger is expected to talk about the company's growth opp... 
Printer Friendly Version
More

Upcoming Events
There are currently no events scheduled.
More

Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Bacterin International Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.